BioSpace News Archive

Policy

Assertio Therapeutics Announces Favorable Nucynta® Patent Ruling

Assertio Therapeutics, Inc. announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Assertio with respect to the company’s patent litigation against three filers of Abbreviated New Drug Applications for the NUCYNTA® franchise.

March 28, 2019
·
2 min read
Business

XenTech Signs Strategic Collaboration Agreement with Gustave Roussy Cancer Center

Specialized CRO and Leading Cancer Center to Develop New Panel of Patient-Derived Xenograft (PDX) Models from Patients with Acquired Resistance to Last-Generation Targeted Drugs in Oncology

March 28, 2019
·
3 min read
Deals

Microbix Announces Annual Meeting Voting Results

Microbix Biosystems Inc., an innovator of biological products and technologies, announces the voting results from the Annual Meeting of Shareholders which was held on March 27, 2019.

March 28, 2019
·
3 min read
BioForest

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

Companies Plan to Submit Biologics License Application Later This Year

March 28, 2019
·
9 min read
BioForest

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer - March 28, 2019

Seattle Genetics, Inc. and Astellas Pharma Inc. announced positive topline results from the first cohort of patients in a pivotal phase 2 single-arm clinical trial known as EV-201.

March 28, 2019
·
10 min read
Pharm Country

New York City Will Walk To End Pancreatic Cancer At Its 10th Annual PurpleStride®

PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and Improve Patient Outcomes

March 28, 2019
·
4 min read
OBI Pharma Announces Poster Presentations at AACR 2019 for Novel Globo H Immuno-Oncology Therapeutics: OBI-888 and OBI-999

Poster Presentations to highlight on mechanism of action, anti-tumor efficacy and pharmacokinetics profile for OBI-888 (Globo H mAb) and OBI-999 (Globo H ADC)

March 28, 2019
·
4 min read
Biotech Bay

Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia

Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates

March 28, 2019
·
4 min read
Business

Technogym S.p.A.: Board of Directors Approved the Draft Consolidated Results for the 2018 Financial Year

CONSOLIDATED REVENUE: Euro 634 million, +8% on 2017. At constant exchange rates, consolidated revenue growth stands at +10%

March 28, 2019
·
2 min read
Business

Evolent Health, GlobalHealth and Kinderhook Industries Launch “True Health” to Support Provider-Led Medicare Advantage Plans

Newly established joint venture True Health partners with leading providers to offer Medicare Advantage plans in targeted geographies

March 28, 2019
·
7 min read